Selection of Allogeneic Hematopoietic Cell Donors Based on KIR and HLA Genotypes

NAActive, not recruitingINTERVENTIONAL
Enrollment

511

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

May 31, 2026

Study Completion Date

May 31, 2026

Conditions
Leukemia
Interventions
GENETIC

KIR genotyping

GENETIC

HLA genotyping

Trial Locations (10)

10065

Memorial Sloan Kettering Cancer Center, New York

27701

Duke University Medical Center, Durham

33612

Moffitt Cancer Center, Tampa

43210

Ohio State University, Columbus

55905

Mayo Clinic Cancer Center, Rochester

75246

Baylor University Medical Center, Dallas

77030

Md Anderson Cancer Center, Houston

98109

University of Washington School of Medicine, Seattle

02115

Dana Farber Cancer Institute, Boston

07601

Hackensack University Medical Center Cancer Center, Hackensack

Sponsors
All Listed Sponsors
collaborator

Center for International Blood and Marrow Transplant Research

NETWORK

collaborator

Hackensack Meridian Health

OTHER

collaborator

H. Lee Moffitt Cancer Center and Research Institute

OTHER

collaborator

M.D. Anderson Cancer Center

OTHER

collaborator

Dana-Farber Cancer Institute

OTHER

collaborator

University of Washington

OTHER

collaborator

Mayo Clinic

OTHER

collaborator

Duke University

OTHER

lead

Memorial Sloan Kettering Cancer Center

OTHER